saxenda a glp 1 (liraglutide) for the Treatment of Obesity, US Saxenda® Prescription Online for Weight

And as long as it's continued to completion, I don't think efficacy is really a question at this point either. However, lower dosing often means a longer treatment course

The coordinated operation spans across social media, paid ads, and dedicated scam websites, putting patients safety and brand reputations at serious risk

Our Research Lead examined anonymized platform data from: 5,864 US adults using tirzepatide (Mounjaro or Zepbound) 4,456 US adults using semaglutide (Ozempic or Wegovy) Inclusion criteria: Active GLP-1 therapy with weekly injections Minimum 12-week tracking duration Adherence threshold: 1 injection log and 1 weight entry per week No weight entries outside physiological bounds (30300 kg) or with weekly changes exceeding 5% Primary outcome: Percentage body weight change from baseline, calculated as [(current weight baseline weight) / baseline weight] 100 , where negative values indicate weight loss Data collection period: Data were collected from all available platform records through January 2026, representing naturalistic use patterns without researcher intervention

Med Pharm Rep

Boehringer Ingelheims survodutide (glucagon/GLP-1), the first new competitor to enter the market outside the dominant Novo Nordisk/Lilly duopoly